RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Source: JNCI - Category: Cancer & Oncology Authors: Tags: Correspondence Source Type: research